Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR2 Exon 18 Truncation Variants Are Therapeutically Actionable in Cancer.

Cancer discovery - 5 Oct 2022

Abstract excerpt

Variants leading to FGFR2 exon 18 truncation function as an oncogenic driver mutation.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Exons
Share to Mutation
Share to Neoplasms
Share to Receptor, Fibroblast Growth Factor, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36018033
DOI: 10.1158/2159-8290.CD-RW2022-155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR2 Exon 18 Truncation Variants Are Therapeutically Actionable in Cancer.PMID 36018033Read ↗

The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.Semantic proximity Read ↗

FGFR rearrangements: oncogenic drivers and therapeutic targets.Semantic proximity Read ↗

Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.Semantic proximity Read ↗

Fast-TRKing Drug Development for Rare Molecular Targets.Semantic proximity Read ↗

Expression analysis of an FGFR2 IIIc 5' splice site mutation (1084+3A->G).Semantic proximity Read ↗

Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2.Semantic proximity Read ↗

Afatinib in Advanced Lung Squamous Cancer Harboring HER2 Mutation in Exon 17 Plus Amplification.Semantic proximity Read ↗

Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?Semantic proximity Read ↗

Fibroblast growth factor receptor-4 splice variants cause deletion of a critical tyrosine.Semantic proximity Read ↗

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.Semantic proximity Read ↗

A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.Semantic proximity Read ↗

Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.